U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07526519) titled 'A Safety and Pharmacokinetics Study of TL-001 in Healthy Adults and Open-label Assessments in Participants With Ulcerative Colitis' on April 06.
Brief Summary: The goal of this study is to evaluate safety, tolerability, pharmacokinetics (PK)), pharmacodynamics (PD) and immunogenicity of single and multiple ascending dose of TL-003 in healthy adult participants.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: TL-003
Intravenously administered
DRUG: Placebo
Intravenously administered
Recruitment Status: RECRUITING
Sponsor: TrueLab Biopharmaceutical Co., Ltd
Disclai...